Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

Announcement on Postponing the 4th Extraordinary General Meeting in 2025 for Another Time

· Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Postponing the 4th Extraordinary General Meeting in 2025 for Another Time

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment